How many tablets of Diclofenac Sodium Enteric-coated Tablets should be taken at a time?

Update Date: Source: Network

Diclofenac Sodium Enteric-coated Tablets are a common medication, and the daily dosage should not exceed two or three times. Taking too much of it will have the opposite effect. Once symptoms appear in the body, it is necessary to immediately start the treatment with this medication. After taking the medication for a period of time, the dosage can be adjusted based on the improvement of the condition. Do not change it arbitrarily. As a general rule, the initial daily dose is 100-150mg (4 to 6 tablets). For mild patients or those requiring long-term treatment, the daily dose is 75-100mg (3 to 4 tablets). The daily dose is usually divided into 2-3 administrations. To reduce night pain and morning stiffness, tablets can be used during the day, while suppositories can be used before bedtime as an adjunct (the maximum daily dose does not exceed 150mg). For primary dysmenorrhea, the usual daily dose needs to be adjusted individually, generally 50-150mg (2 to 6 tablets), taken in divided doses. The initial dose should be 50-100mg (2 to 4 tablets), and if necessary, the dose can be increased over several menstrual cycles to a maximum daily dose of 200mg (8 tablets). Treatment should be started immediately upon the appearance of symptoms and continued for several days, with the treatment plan depending on the symptoms. Children and adolescents: For children and adolescents aged 1 year or older, the daily dose is 0.5-2mg/kg of body weight, divided into 2-3 administrations, based on the condition. For juvenile rheumatoid arthritis, the daily dose can be up to 3mg/kg of body weight, taken in divided doses. The maximum daily dose is 150mg. Due to the large dose of 50mg Voltaren® Enteric-coated Tablets, it is not recommended for children and adolescents under 14 years old, but 25mg tablets can be used instead. This product should not be used in infants under 12 months old. There is currently no evidence to suggest that diclofenac potassium has a synergistic effect when combined with other systemic non-steroidal anti-inflammatory drugs (including cyclooxygenase-2 selective inhibitors), and there may be potential additional adverse reactions, so combination therapy should be avoided. The precautions for medication use in the elderly should follow the basic principles of medical treatment. Special attention should be paid to patients who are physically weak or underweight, and the smallest effective dose should be administered. Since diclofenac sodium contains lactose, it is not recommended for patients with the following rare genetic conditions: galactose intolerance, severe lactase deficiency, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency, or a history of asthma. In patients with asthma, seasonal allergic rhinitis, nasal mucosa edema (such as nasal polyps), chronic obstructive pulmonary disease, or chronic respiratory infections (especially if associated with allergic rhinitis-like symptoms), non-steroidal drug-like reactions such as asthma exacerbations (so-called analgesic/analgesic-asthma intolerance), Quincke's edema, or urticaria may be more common than in other patients. Therefore, special attention should be paid to these patients (prepare for emergencies). Patients allergic to other substances, such as those with skin reactions, itching, or urticaria, should also be cautious.